Pathological complete response after cisplatin neoadjuvant therapy is associated with the downregulation of DNA repair genes in BRCA1-associated triple-negative breast cancers

Pathologic complete response (pCR) after neoadjuvant chemotherapy is considered a suitable surrogate marker of treatment efficacy in patients with triple-negative breast cancers (TNBCs). However, the molecular mechanisms underlying pCR as a result of such treatment remain obscure. Using real-time PC...

Descripción completa

Detalles Bibliográficos
Autores principales: Domagala, Pawel, Hybiak, Jolanta, Rys, Janusz, Byrski, Tomasz, Cybulski, Cezary, Lubinski, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356581/
https://www.ncbi.nlm.nih.gov/pubmed/27626685
http://dx.doi.org/10.18632/oncotarget.11900

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356581/
https://www.ncbi.nlm.nih.gov/pubmed/27626685
http://dx.doi.org/10.18632/oncotarget.11900

Ejemplares similares